Idera Pharmaceuticals Inc (NASDAQ:IDRA)

2.05
Delayed Data
As of Aug 12
 -0.12 / -5.53%
Today’s Change
0.81
Today|||52-Week Range
3.58
+12.64%
Year-to-Date
Checkmate Pharmaceuticals Begins IPO Process
Jul 31 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close2.17
Today’s open2.14
Day’s range2.05 - 2.14
Volume2,533
Average volume (3 months)318,307
Market cap$73.6M
Data as of 3:59pm ET, 08/12/2020

Growth & Valuation

Earnings growth (last year)-31.59%
Earnings growth (this year)+68.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+118.73%
P/E ratioNM
Price/Sales35.88
Price/Book--

Competitors

----
ETTXEntasis Therapeutics...-0.02-0.68%
SAVACassava Sciences Inc+0.44+15.07%
OCGNOcugen Inc-0.00-0.82%
Data as of 4:58pm ET, 08/12/2020

Financials

Next reporting dateNovember 4, 2020
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.4M
Annual profit (last year)-$56.5M
Net profit margin-3,902.97%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Exton, Pennsylvania

Forecasts